ATE354654T1 - Identifizierung humaner zellinien zur produktion humaner proteine durch endogene genaktivierung - Google Patents

Identifizierung humaner zellinien zur produktion humaner proteine durch endogene genaktivierung

Info

Publication number
ATE354654T1
ATE354654T1 AT98942592T AT98942592T ATE354654T1 AT E354654 T1 ATE354654 T1 AT E354654T1 AT 98942592 T AT98942592 T AT 98942592T AT 98942592 T AT98942592 T AT 98942592T AT E354654 T1 ATE354654 T1 AT E354654T1
Authority
AT
Austria
Prior art keywords
human
production
gene activation
endogene
identification
Prior art date
Application number
AT98942592T
Other languages
German (de)
English (en)
Inventor
Michael Brandt
Reinhard Franze
Ulrich Pessara
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27238256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE354654(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/113,692 external-priority patent/US6548296B1/en
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE354654T1 publication Critical patent/ATE354654T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98942592T 1997-07-23 1998-07-22 Identifizierung humaner zellinien zur produktion humaner proteine durch endogene genaktivierung ATE354654T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97112640 1997-07-23
EP97121073 1997-12-01
US09/113,692 US6548296B1 (en) 1997-07-23 1998-07-10 Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof

Publications (1)

Publication Number Publication Date
ATE354654T1 true ATE354654T1 (de) 2007-03-15

Family

ID=27238256

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98942592T ATE354654T1 (de) 1997-07-23 1998-07-22 Identifizierung humaner zellinien zur produktion humaner proteine durch endogene genaktivierung

Country Status (14)

Country Link
US (1) US6395484B1 (da)
EP (1) EP1000154B1 (da)
JP (1) JP2001511342A (da)
CN (1) CN1150319C (da)
AT (1) ATE354654T1 (da)
AU (1) AU737605B2 (da)
BR (1) BR9811542A (da)
CA (1) CA2298412C (da)
DE (1) DE59813913D1 (da)
DK (1) DK1000154T3 (da)
ES (1) ES2281133T3 (da)
TR (1) TR200000140T2 (da)
TW (1) TWI224140B (da)
WO (1) WO1999005267A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100622203B1 (ko) * 1997-07-23 2006-09-07 로셰 디아그노스틱스 게엠베하 내인성 유전자 활성화에 의해 사람 단백질을 생성시키는 사람 세포주를 확인하는 방법
GB0200977D0 (en) * 2002-01-17 2002-03-06 Lonza Biologics Plc Glutamine-auxotrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
WO2003054172A2 (en) * 2002-01-17 2003-07-03 Lonza Biologics Plc. Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US11311574B2 (en) 2003-08-08 2022-04-26 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
GB2426523B (en) 2004-03-01 2008-10-22 Kitakyushu Foundation Human cell strains for protein production,provided by selecting strains with high intracellular protein and mutating with carcinogens
DE102012009849A1 (de) 2012-05-21 2013-11-21 Hartwig Schwieger Schwingungsstabilisierte Windenergieanlage-Zug-Druck-Knoten
JP6652334B2 (ja) 2014-05-31 2020-02-19 Ｊｃｒファーマ株式会社 ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
US12527950B2 (en) 2018-07-09 2026-01-20 NanoCav, LLC Electroporation devices and methods of cell transfection
WO2020014264A1 (en) * 2018-07-09 2020-01-16 NanoCav, LLC Micro flow-through electroporation devices and methods of cell transfection
US12188042B2 (en) 2018-07-09 2025-01-07 NanoCav, LLC Electroporation devices and methods of cell transfection

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) * 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
JPS62171696A (ja) * 1986-01-23 1987-07-28 Sumitomo Chem Co Ltd ヒトエリスロポエチンの製造方法
US4954437A (en) * 1986-09-15 1990-09-04 Integrated Genetics, Inc. Cell encoding recombinant human erythropoietin
JP2879906B2 (ja) * 1989-09-14 1999-04-05 鐘紡株式会社 プロコラゲナーゼの製造方法
EP0945515A3 (en) * 1989-11-06 2002-08-21 Cell Genesys, Inc. Production of proteins using homologous recombination
US5328844A (en) * 1990-05-09 1994-07-12 University Of Colorado Foundation, Inc. Culture media for mammalian cells
PT101031B (pt) * 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5449015A (en) * 1994-05-12 1995-09-12 Petkovic; Tony Shock-activated shut-off valve

Also Published As

Publication number Publication date
DK1000154T3 (da) 2007-06-18
JP2001511342A (ja) 2001-08-14
DE59813913D1 (de) 2007-04-05
ES2281133T3 (es) 2007-09-16
US6395484B1 (en) 2002-05-28
BR9811542A (pt) 2000-08-22
TWI224140B (en) 2004-11-21
EP1000154B1 (de) 2007-02-21
CA2298412C (en) 2010-10-19
CN1150319C (zh) 2004-05-19
WO1999005267A1 (de) 1999-02-04
CA2298412A1 (en) 1999-02-04
TR200000140T2 (tr) 2000-05-22
CN1265144A (zh) 2000-08-30
EP1000154A1 (de) 2000-05-17
AU737605B2 (en) 2001-08-23
AU9067498A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
ATE354654T1 (de) Identifizierung humaner zellinien zur produktion humaner proteine durch endogene genaktivierung
EP1650307A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
IS4626A (is) Ferli til stýringar á síalsýrumagni próteina sem framleiddar eru í spendýrafrumurækt
DE69940525D1 (de) Zubereitung, die einen zellextrakt zur herstellung eines zellfreien proteins enthalten und vorrichtung zur herstellung eines zellfreien proteins
ATE237312T1 (de) In liposomen verkapselte nukleinsäurekomplexe
AR020735A1 (es) Un procedimiento para la obtencion de un polipeptido glucosilado a partir de celulas eucarioticas
WO2002029083A3 (en) Industrial-scale serum-free production of recombinant proteins in mammalian cells
TR200401091T4 (tr) Gelişim faktörleri ve L-glutamin içeren hücre kültürü besiyeri
AU2002316230A1 (en) Methods of culturing animal cells and polypeptide production in animal cells
ATE517185T1 (de) Methoden zur herstellung von pflanzen mit erhöhtem ölsäuregehalt
ATA165999A (de) Medium zur protein- und serumfreien kultivierung von zellen
DE60020940D1 (de) Verfahren zur ethanolherstellung mit kontinuierliche beimischung von hefe
ATE219380T1 (de) Vehikel zum einbringen von nukleinsäuren in zellen
ATE274577T1 (de) Stammzellen-proliferations-faktor
TR200000175T2 (tr) Endogenik gen aktivasyonu ile eritropoietinin hazırlanması.
DE60214400D1 (de) Verfahren zur proteinproduktion in pflanzen
ATE408020T1 (de) Verfahren zur herstellung von faktor vii
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
DE59912826D1 (de) Kulturvorrichtung und verfahren zur kultivierung von zellen oder gewebekomponenten
EP0310056A3 (en) Thymic stroma-derived t cell growth factor and process for its production
AUPM772494A0 (en) Improvements in production of proteins in host cells
DE69933699D1 (de) Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin
CA2441535A1 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
DE60334372D1 (de) Verfahren zur herstellung von gewebekonstrukten
DE69939876D1 (de) Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren